• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT Back to Search Results
Device Problem Degraded (1153)
Patient Problems Pain (1994); Swelling/ Edema (4577)
Event Date 07/31/2020
Event Type  Injury  
Manufacturer Narrative
Literature citation: fogleman et al.Failed hydrogel synthetic cartilage implant with osteolytic cyst formation in the first metatarsophalangeal joint.Sagef journal.2020; volume 5 issue 3.The device was not returned for evaluation.Films in the article were provided and found to show post implantation of a synthetic cartilage implant.Imaging demonstrates ballooning osteolysis about the first mtp joint space.Mtp, metatarsophalangeal.
 
Event Description
Allegedly it was reported in a journal article titled failed hydrogel synthetic cartilage implant with osteolytic cyst formation in the first metatarsophalangeal joint p.The patient reported that since the time of the index procedure, the patient had continued to have pain and swelling about the great toe.Imaging at the time of this initial encounter demonstrated a right first mtpj status post implantation of the hydrogel implant with subsequent joint collapse, implant loosening, and ballooning osteolysis in both the first metatarsal and proximal phalanx.There was no evidence for cystic changes on radiographs prior to placement of her hydrogel implant.Because of the patients clinical appearance and radiographic findings, the patient was sent for blood work including erythrocyte sedimentation rate (esr), c-reactive protein (crp), and complete blood count (cbc) with differentiation, all of which came back with normal values.Additionally, a computed tomography (ct) scan of the right foot was ordered to further define bone loss.One month later, the patient returned for reevaluation.The patient was continuing to have pain and swelling about the great toe.After a discussion of the risks and benefits of surgery, we proceeded with right first mtpj removal of implant and fusion with cancellous autograft 3 weeks later.A dorsal approach was made over the first mtpj following the previous operative incision.There was a large degree of reactive tissue around the hydrogel implant.The implant was grossly loose, and it was removed without difficulty.The implant demonstrated pitting and wear.A curette was then used to excavate the cyst present within the metatarsal and phalanx.Cystic tissue was sent for culture and pathology.The patient received utologous cancellous bone graft and conversion to fusion.
 
Manufacturer Narrative
Literature citation: fogleman et al.Failed hydrogel synthetic cartilage implant with osteolytic cyst formation in the first metatarsophalangeal joint.Sagef journal.2020; volume 5 issue 3.H6: the case report provided images.Among the images was one of the cartiva device which the report claimed exhibited pitting and wear.Although the image does appear to confirm what looks like pitting and denting along the articular surface, it is not possible to confirm that these are attributed to wear without physically measuring and weighing the device.
 
Event Description
Allegedly it was reported in a journal article titled failed hydrogel synthetic cartilage implant with osteolytic cyst formation in the first metatarsophalangeal joint p.The patient reported that since the time of the index procedure, the patient had continued to have pain and swelling about the great toe.Imaging at the time of this initial encounter demonstrated a right first mtpj status post implantation of the hydrogel implant with subsequent joint collapse, implant loosening, and ballooning osteolysis in both the first metatarsal and proximal phalanx.There was no evidence for cystic changes on radiographs prior to placement of her hydrogel implant.Because of the patients clinical appearance and radiographic findings, the patient was sent for blood work including erythrocyte sedimentation rate (esr), c-reactive protein (crp), and complete blood count (cbc) with differentiation, all of which came back with normal values.Additionally, a computed tomography (ct) scan of the right foot was ordered to further define bone loss.One month later, the patient returned for reevaluation.The patient was continuing to have pain and swelling about the great toe.After a discussion of the risks and benefits of surgery, we proceeded with right first mtpj removal of implant and fusion with cancellous autograft 3 weeks later.A dorsal approach was made over the first mtpj following the previous operative incision.There was a large degree of reactive tissue around the hydrogel implant.The implant was grossly loose, and it was removed without difficulty.The implant demonstrated pitting and wear.A curette was then used to excavate the cyst present within the metatarsal and phalanx.Cystic tissue was sent for culture and pathology.The patient received utologous cancellous bone graft and conversion to fusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTIVA IMPLANT
Type of Device
PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT
Manufacturer (Section D)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
MDR Report Key11029434
MDR Text Key222101638
Report Number3009351194-2020-00020
Device Sequence Number1
Product Code PNW
Combination Product (y/n)N
PMA/PMN Number
K181348
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 11/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/22/2020
Initial Date FDA Received12/17/2020
Supplement Dates Manufacturer Received11/22/2020
Supplement Dates FDA Received02/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-